News

The Class of 2022 adds to Weill Cornell Medicine’s diverse community. Its students hail from 18 countries and collectively speak 29 different languages. 

U.S. News & World Report survey recognizes NewYork-Presbyterian Hospital for its excellence in numerous specialties.

By sabotaging one of the tuberculosis bacterium’s defenses against antibiotics, Weill Cornell Medicine investigators may have found a way to accelerate treatment for the disease and possibly overcome growing resistance to existing therapies.  

Sensory stimulation during a critical period soon after birth is essential for establishing networks in the brain...

Dr. Kaushal is one of 78 women chosen by Crain’s New York Business to honor female professionals working in healthcare whose contributions have significantly influenced New York City. http://www.crainsnewyork.com/assets/pdf/CN11652782.PDFhttp://hpr.weill.cornell.edu/https://www.joinallofus.org/en/nyc

A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research from investigators at Weill Cornell Medicine, Cornell’s Meinig School of Biomedical Engineering and NewYork-Presbyterian.

NEW YORK (July 30, 2018)—Dr. Laura Riley, a renowned obstetrician who specializes in obstetric...

Awards, honors, prizes and achievements for the month of July.

Conventional wisdom suggests that a high level of the protein prostate specific antigen (PSA) in men with prostate cancer means a poor prognosis. However, this may not always be the case in men with a particular subtype of prostate cancer, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers.

A minimally invasive procedure to replace the heart’s aortic valve has recently increased in popularity despite a lack of research on the new valves’ long-term durability, according to a new study from Weill Cornell Medicine.

Two years ago, in a remote region of Ecuador, ophthalmologist Dr. Elwin Schwartz, MD ’76, helped give a six-year-old girl the gift of sight. 

New molecules engineered by Weill Cornell Medicine researchers can enable rapid, direct “editing” of genes in a wide range of cell types, creating an array of research and therapeutic possibilities.

Weill Cornell Medicine, in collaboration with Columbia University Irving Medical Center and NewYork-Presbyterian, has been awarded a $900,000 grant from the U.S. Department of Defense (DoD) to conduct prostate cancer clinical trials.

Dr. Shuibing Chen, an associate professor of chemical biology in surgery and in biochemistry at Weill Cornell Medicine, has received the ISSCR Dr. Susan Lim Award for Outstanding Young Investigator from the International Society for Stem Cell Research (ISSCR).

Dr. Francis Lee, a leading physician-scientist whose research focuses on anxiety disorders, has been named chairman of the Department of Psychiatry at Weill Cornell Medicine and psychiatrist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Treating early-stage lung cancers with drugs that unleash the immune system’s ability to attack malignant cells may hinder tumor growth and improve overall survival, according to new research by Weill Cornell Medicine and NewYork-Presbyterian investigators. 

Today’s headlines can seem a grim litany of disasters, from hurricanes in the Atlantic and epidemics in South America to conflicts in Africa and droughts in the Midwest. For Dr. Alan Lockwood ’65, MD ’69, though, these calamities all have two things in common: they’re rooted in climate change, and they’re signs of public health crises that the medical profession—as well as other scientists, policymakers and citizens around the world—must address.

Gene mutations detected in blood may predict risk of one of the most common forms of adult leukemia a decade before patients are diagnosed with the disease, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

For Ralph Hills, getting ready for minor back surgery in December 2014 was no big deal. At 71, the computer consultant was physically fit—regularly playing golf and tennis—and his heart and lungs were in good shape. So when he went for a routine pre-operative blood test, he never expected to get a call referring him to an oncologist near where he lives in suburban Connecticut.

An existing malaria drug could improve the effectiveness of a new class of cancer therapies, called glutaminase inhibitors, if used in combination, researchers at Weill Cornell Medicine-Qatar (WCM-Q) discovered in a new study.